Spinal fusion is still considered the gold standard for treatment of LBP due to DDD, but it may not hold that title for much longer. Holding spinal fusion as the optimal treatment was based on the assumption that a degenerated spinal segment is either unstable or moves outside of the normal range of motion. Both [...]
The markets which encompass Asia-Pacific are generally somewhat more mature markets which have seen these products and have been using these technologies. Hence, for spinal fusion, for example, the tendency away from fusion and towards intermediate treatments will be seen in the years to come.
Fusion markets in this region, at over $80 million annually in [...]
Contact:
